Ticker

Analyst Price Targets — ABEO

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 17, 2026 7:53 pmStephen WilleyStifel Nicolaus$17.00$4.76StreetInsider Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates
May 16, 2025 12:02 pmStephen WilleyStifel Nicolaus$20.00$6.10TheFly Abeona Therapeutics price target lowered to $20 from $21 at Stifel
March 5, 2025 12:18 pmOppenheimer$16.00$5.26TheFly Abeona Therapeutics initiated with an Outperform at Oppenheimer
November 14, 2022 1:42 pmLeerink Partners$6.00$4.15Benzinga SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6

Latest News for ABEO

Abeona Therapeutics Q1 Earnings Call Highlights

Abeona Therapeutics NASDAQ: ABEO reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center activation and a newly licensed prostate cancer cell therapy program during the company's earnings call.

MarketBeat • May 13, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for ABEO.

No House trades found for ABEO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top